miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
Wang Y, Lieberman R, Pan J, Zhang Q, Du M, Zhang P, Nevalainen M, Kohli M, Shenoy NK, Meng H, You M, Wang L.
Wang Y, et al. Among authors: wang l.
Mol Cancer. 2016 Nov 10;15(1):70. doi: 10.1186/s12943-016-0556-9.
Mol Cancer. 2016.
PMID: 27832783
Free PMC article.